72
Overbought
Moving averages
SMA 200$42.34+2.01%
Company profile
Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
SectorHealthcare
IndustryDiagnostics & Research
Market cap$3.32B
P/E ratio29.46
EPS$1.40
Beta1.94
Dividend yield0.00%
52-week high$60.91
52-week low$28.25
Similar stocks in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
RSI 52
ILMN
Illumina Inc
RSI 52
MTD
Mettler-Toledo International Inc
RSI 55
CSTL
Castle Biosciences Inc
RSI 60
FONR
Fonar Corp
RSI 75
CRL
Charles River Laboratories International Inc
RSI 64
BDSX
Biodesix Inc
RSI 55
NTRA
Natera Inc
RSI 59
WGS
GeneDx Holdings Corp - Class A
RSI 61
DGX
Quest Diagnostics Inc
RSI 36
RSI alerts for VCYT
Get an email the moment Veracyte Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 16 August 2026 at 1:45 AM EDT